Rozenberg, Roberto; Pereira, Lygia da Veiga (2001). „The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program”. Sao Paulo Medical Journal. 119 (4): 146—149. PMID11500789. doi:10.1590/s1516-31802001000400007..
Myerowitz, R.; Costigan, F. C. (1988). „The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase”. The Journal of Biological Chemistry. 263 (35): 18587—18589. PMID2848800. doi:10.1016/S0021-9258(18)37323-X.
Frisch, Amos; Colombo, Roberto; Michaelovsky, Elena; Karpati, Mazal; Goldman, Boleslaw; Peleg, Leah (2004). „Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: Genetic drift as a robust and parsimonious hypothesis”. Human Genetics. 114 (4): 366—376. PMID14727180. S2CID10768286. doi:10.1007/s00439-003-1072-8.
Nolan, D.; Carlson, M. (јун 2016). „Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis”. Journal of Child Neurology. 31 (7): 887—94. PMID26863999. S2CID206552341. doi:10.1177/0883073815627880.CS1 одржавање: Формат датума (веза).
Kaback, Michael M. (2000). „Population-based genetic screening for reproductive counseling: The Tay-Sachs disease model”. European Journal of Pediatrics. 159: S192—S195. ISSN1432-1076. PMID11216898. S2CID5808156. doi:10.1007/PL00014401.
Myerowitz, R.; Costigan, F. C. (1988). „The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase”. Journal of Biological Chemistry. 263 (35): 18587—18589. PMID2848800. doi:10.1016/S0021-9258(18)37323-X.
Keats, Bronya J. B.; Elston, Robert C.; Andermann, Eva; Rao, D. C. (1987). „Pedigree discriminant analysis of two French Canadian Tay-Sachs families”. Genetic Epidemiology. 4 (2): 77—85. PMID2953646. S2CID23770703. doi:10.1002/gepi.1370040203.
Mahuran, Don J. (1999). „Biochemical consequences of mutations causing the GM2 gangliosidoses”. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1455 (2–3): 105—138. PMID10571007. doi:10.1016/S0925-4439(99)00074-5..
Specola, N.; Vanier, M. T.; Goutieres, F.; Mikol, J.; Aicardi, J. (1990). „The juvenile and chronic forms of GM2 gangliosidosis: Clinical and enzymatic heterogeneity”. Neurology. 40 (1): 145—150. PMID2136940. S2CID19301606. doi:10.1212/wnl.40.1.145.
Saleh, Osama; MacQueen, G. M.; Clarke, J. T.; Callahan, J. W.; Strasberg, P. M.; Mazurek, M. F. (2000). „Late Onset Tay-Sachs Disease Presenting as a Brief Psychotic Disorder with Catatonia: A Case Report and Review of the Literature”. Jefferson Journal of Psychiatry. 15 (8): 347—353. PMID7635850. doi:10.29046/JJP.015.1.006.
Aragão, Ricardo Evangelista Marrocos de; Ramos, Régia Maria Gondim; Pereira, Felipe Bezerra Alves; Bezerra, Andreya Ferreira Rodrigues; Fernandes, Daniel Nogueira (2009). „"Cherry red spot" in a patient with Tay-Sachs disease: Case report”. Arquivos Brasileiros de Oftalmologia. 72 (4): 537—539. PMID19820796. doi:10.1590/S0004-27492009000400019..
Kronn, D.; Jansen, V.; Ostrer, H. (1998). „Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: The first 1000 cases at New York University Medical Center, New York, NY”. Archives of Internal Medicine. 158 (7): 777—781. PMID9554684. doi:10.1001/archinte.158.7.777.
Rozenberg, R.; Pereira Lda, V. (2001). „The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program”. Sao Paulo Medical Journal = Revista Paulista de Medicina. 119 (4): 146—149. PMID11500789. doi:10.1590/s1516-31802001000400007.
Lew, R. M.; Burnett, L.; Proos, A. L.; Barlow-Stewart, K.; Delatycki, M. B.; Bankier, A.; Aizenberg, H.; Field, M. J.; Berman, Y.; Fleischer, R.; Fietz, M. (2015). „Ashkenazi Jewish population screening for Tay-Sachs disease: The international and Australian experience”. Journal of Paediatrics and Child Health. 51 (3): 271—279. PMID24923490. S2CID206133450. doi:10.1111/jpc.12632.
Natowicz, M. R.; Prence, E. M. (1996). „Heterozygote screening for Tay-Sachs disease: Past successes and future challenges”. Current Opinion in Pediatrics. 8 (6): 625—629. PMID9018448. doi:10.1097/00008480-199612000-00014.
Rozenberg, Roberto; Pereira, Lygia da Veiga (2001). „The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program”. Sao Paulo Medical Journal. 119 (4): 146—149. PMID11500789. doi:10.1590/s1516-31802001000400007..
Myerowitz, R.; Costigan, F. C. (1988). „The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase”. The Journal of Biological Chemistry. 263 (35): 18587—18589. PMID2848800. doi:10.1016/S0021-9258(18)37323-X.
Frisch, Amos; Colombo, Roberto; Michaelovsky, Elena; Karpati, Mazal; Goldman, Boleslaw; Peleg, Leah (2004). „Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: Genetic drift as a robust and parsimonious hypothesis”. Human Genetics. 114 (4): 366—376. PMID14727180. S2CID10768286. doi:10.1007/s00439-003-1072-8.
Nolan, D.; Carlson, M. (јун 2016). „Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis”. Journal of Child Neurology. 31 (7): 887—94. PMID26863999. S2CID206552341. doi:10.1177/0883073815627880.CS1 одржавање: Формат датума (веза).
Kaback, Michael M. (2000). „Population-based genetic screening for reproductive counseling: The Tay-Sachs disease model”. European Journal of Pediatrics. 159: S192—S195. ISSN1432-1076. PMID11216898. S2CID5808156. doi:10.1007/PL00014401.
Myerowitz, R.; Costigan, F. C. (1988). „The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase”. Journal of Biological Chemistry. 263 (35): 18587—18589. PMID2848800. doi:10.1016/S0021-9258(18)37323-X.
Keats, Bronya J. B.; Elston, Robert C.; Andermann, Eva; Rao, D. C. (1987). „Pedigree discriminant analysis of two French Canadian Tay-Sachs families”. Genetic Epidemiology. 4 (2): 77—85. PMID2953646. S2CID23770703. doi:10.1002/gepi.1370040203.
Ohno, K.; Suzuki, K. (1988). „Multiple abnormal beta-hexosaminidase alpha chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease”. Journal of Biological Chemistry. 263 (34): 18563—18567. PMID2973464. doi:10.1016/S0021-9258(19)81396-0..
Adam, M. P.; Mirzaa, G. M.; Pagon, R. A.; Wallace, S. E.; Bean LJH; Gripp, K. W.; Amemiya, A.; Toro, C.; Shirvan, L.; Tifft, C. (1993). „HEXA Disorders”. PMID20301397..
Mahuran, Don J. (1999). „Biochemical consequences of mutations causing the GM2 gangliosidoses”. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1455 (2–3): 105—138. PMID10571007. doi:10.1016/S0925-4439(99)00074-5..
Specola, N.; Vanier, M. T.; Goutieres, F.; Mikol, J.; Aicardi, J. (1990). „The juvenile and chronic forms of GM2 gangliosidosis: Clinical and enzymatic heterogeneity”. Neurology. 40 (1): 145—150. PMID2136940. S2CID19301606. doi:10.1212/wnl.40.1.145.
Saleh, Osama; MacQueen, G. M.; Clarke, J. T.; Callahan, J. W.; Strasberg, P. M.; Mazurek, M. F. (2000). „Late Onset Tay-Sachs Disease Presenting as a Brief Psychotic Disorder with Catatonia: A Case Report and Review of the Literature”. Jefferson Journal of Psychiatry. 15 (8): 347—353. PMID7635850. doi:10.29046/JJP.015.1.006.
Aragão, Ricardo Evangelista Marrocos de; Ramos, Régia Maria Gondim; Pereira, Felipe Bezerra Alves; Bezerra, Andreya Ferreira Rodrigues; Fernandes, Daniel Nogueira (2009). „"Cherry red spot" in a patient with Tay-Sachs disease: Case report”. Arquivos Brasileiros de Oftalmologia. 72 (4): 537—539. PMID19820796. doi:10.1590/S0004-27492009000400019..
Kronn, D.; Jansen, V.; Ostrer, H. (1998). „Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: The first 1000 cases at New York University Medical Center, New York, NY”. Archives of Internal Medicine. 158 (7): 777—781. PMID9554684. doi:10.1001/archinte.158.7.777.
Rozenberg, R.; Pereira Lda, V. (2001). „The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program”. Sao Paulo Medical Journal = Revista Paulista de Medicina. 119 (4): 146—149. PMID11500789. doi:10.1590/s1516-31802001000400007.
Lew, R. M.; Burnett, L.; Proos, A. L.; Barlow-Stewart, K.; Delatycki, M. B.; Bankier, A.; Aizenberg, H.; Field, M. J.; Berman, Y.; Fleischer, R.; Fietz, M. (2015). „Ashkenazi Jewish population screening for Tay-Sachs disease: The international and Australian experience”. Journal of Paediatrics and Child Health. 51 (3): 271—279. PMID24923490. S2CID206133450. doi:10.1111/jpc.12632.
Natowicz, M. R.; Prence, E. M. (1996). „Heterozygote screening for Tay-Sachs disease: Past successes and future challenges”. Current Opinion in Pediatrics. 8 (6): 625—629. PMID9018448. doi:10.1097/00008480-199612000-00014.
Kaback, Michael M. (2000). „Population-based genetic screening for reproductive counseling: The Tay-Sachs disease model”. European Journal of Pediatrics. 159: S192—S195. ISSN1432-1076. PMID11216898. S2CID5808156. doi:10.1007/PL00014401.
Keats, Bronya J. B.; Elston, Robert C.; Andermann, Eva; Rao, D. C. (1987). „Pedigree discriminant analysis of two French Canadian Tay-Sachs families”. Genetic Epidemiology. 4 (2): 77—85. PMID2953646. S2CID23770703. doi:10.1002/gepi.1370040203.
Specola, N.; Vanier, M. T.; Goutieres, F.; Mikol, J.; Aicardi, J. (1990). „The juvenile and chronic forms of GM2 gangliosidosis: Clinical and enzymatic heterogeneity”. Neurology. 40 (1): 145—150. PMID2136940. S2CID19301606. doi:10.1212/wnl.40.1.145.
Lew, R. M.; Burnett, L.; Proos, A. L.; Barlow-Stewart, K.; Delatycki, M. B.; Bankier, A.; Aizenberg, H.; Field, M. J.; Berman, Y.; Fleischer, R.; Fietz, M. (2015). „Ashkenazi Jewish population screening for Tay-Sachs disease: The international and Australian experience”. Journal of Paediatrics and Child Health. 51 (3): 271—279. PMID24923490. S2CID206133450. doi:10.1111/jpc.12632.
Flotte, Terence R.; Cataltepe, Oguz; Puri, Ajit; Batista, Ana Rita; Moser, Richard; McKenna-Yasek, Diane; Douthwright, Catherine; Gernoux, Gwladys; Blackwood, Meghan; Mueller, Christian; Tai, Phillip W. L.; Jiang, Xuntian; Bateman, Scot; Spanakis, Spiro G.; Parzych, Julia; Keeler, Allison M.; Abayazeed, Aly; Rohatgi, Saurabh; Gibson, Laura; Finberg, Robert; Barton, Bruce A.; Vardar, Zeynep; Shazeeb, Mohammed Salman; Gounis, Matthew; Tifft, Cynthia J.; Eichler, Florian S.; Brown, Robert H.; Martin, Douglas R.; Gray-Edwards, Heather L.; Sena-Esteves, Miguel (2022). „AAV gene therapy for Tay-Sachs disease”. Nature Medicine. 28 (2): 251—259. ISSN1078-8956. PMID35145305. S2CID246748772. doi:10.1038/s41591-021-01664-4.
Kaback, Michael M. (2000). „Population-based genetic screening for reproductive counseling: The Tay-Sachs disease model”. European Journal of Pediatrics. 159: S192—S195. ISSN1432-1076. PMID11216898. S2CID5808156. doi:10.1007/PL00014401.